Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda.

C. L. Vogel, R. Comis, J. L. Ziegler, J. W. Kiryabwire

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint Dive into the research topics of 'Clinical trials of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) given intravenously in the treatment of malignant melanoma in Uganda.'. Together they form a unique fingerprint.